CBD Oil Market Size
The Global CBD Oil market reached USD 5,294.1 million in 2022 and is projected to witness lucrative growth by reaching up to USD 20,822.1 million by 2031. The market is expected to exhibit a CAGR of 18.67% during the forecast period (2024-2031).
CBD oil is a natural extract derived from the cannabis plant, specifically from hemp, containing cannabidiol (CBD) as its primary active compound. It is non-psychoactive, meaning it does not produce a “high” like THC (tetrahydrocannabinol), and is widely used for its potential therapeutic benefits, including pain relief, anxiety reduction, anti-inflammatory properties, and support for neurological conditions. Available in various forms such as tinctures, capsules, edibles, and topicals, CBD oil has gained popularity as a natural wellness solution.
The global CBD oil market is experiencing significant growth due to increasing consumer awareness of its health benefits, expanding legalization of cannabis-based products, and rising demand across pharmaceuticals, cosmetics, and food & beverages. Additionally, the market is driven by the growing prevalence of chronic pain, anxiety, and neurological disorders, further fueling its adoption worldwide.
Download Free Sample PDF: https://www.datamintelligence.com/download-sample/cbd-oil-market
Market Growth Drivers:
Growing Geriatric Population and Rising Prevalence of Anxiety and Depression to Propel Market Growth
The increasing prevalence of anxiety and depression, coupled with a rapidly growing geriatric population, is a key driver of market growth. Millions worldwide suffer from mental health disorders such as anxiety, stress, and depression. According to the World Health Organization, by 2030, one in six people globally will be aged 60 or older, with the senior population expected to reach 1.4 billion, up from 1 billion in 2020. By 2050, this figure will double to 2.1 billion, while those aged 80 and above will triple to 426 million. This demographic shift is expected to drive significant demand for CBD oil, given its potential to alleviate stress and provide relief for aging individuals.
Increasing Adoption of CBD Oil in Cosmetics and Pharmaceuticals
The growing use of CBD oil in cosmetics, personal care, and pharmaceutical products is another key factor boosting market expansion. Leading market players are launching CBD-based solutions for muscle and joint pain relief, further driving demand. For instance, in October 2021, Synerva CBD Oils introduced a new CBD Joint and Muscle Cream to address pain relief needs. This surge in CBD-infused product development is creating strong market demand, particularly among the elderly population seeking natural remedies for muscle pain and joint discomfort.
Market Segments:
By Product: Original, Blended
By Product Category: Unflavored, Flavored
By Type: THC Dominant, Marijuana-Based, CBD Dominant, Hemp-Based
By Category: Isolate CBD Oil, Full Spectrum CBD Oil, Broad Spectrum CBD Oil
By Application: Pharma & Nutraceuticals, Food and Beverages, Personal Care and Cosmetics, Others
By Distribution Channel: Pharma Retail Store, E-Commerce, Hospital Pharma Retail, Others
By Region: North America, South America, Europe, Asia Pacific, Middle East, and Africa
Competitive Landscape
- Medical Marijuana
- NuLeaf Naturals
- Aurora Cannabis
- Gaia Herbs
- ENDOCA
- Diamond CBD
- FOLIUM BIOSCIENCES
- CV Sciences, Inc
- ConnOils LLC
- IrieCBD
- PureKana
- CBD American Shaman
- Canopy Growth
- Elixinol Global Limited
- Kazmira
Customize Your Scope: https://www.datamintelligence.com/customize/cbd-oil-market
Regional Growth
North America Leads the CBD Oil Market Due to Strong Pharmaceutical Presence
In 2022, North America held the largest market share, driven by the presence of leading pharmaceutical companies and increasing approvals for CBD-based products. The region has witnessed a surge in demand for CBD oil for stress and anxiety relief. Major industry players operating in North America include Canopy Growth Corporation, The Cronos Group, Tilray, Hexo, CannTrust, Aurora Cannabis Inc., GW Pharmaceuticals plc., VIVO Cannabis Inc., Alkaline88, LLC, NewAge Inc., Cannara, Dixie Brands, and The Supreme Cannabis Company, Inc., among others. Additionally, Nextleaf Solutions Ltd., one of the most advanced cannabis extractors, announced that the USPTO granted a patent for a solventless cannabis concentrate production method.
Key Development
On February 22, 2023, Aurora Cannabis Inc., a leading cannabis provider in Canada, partnered with MedReleaf Australia, a top medical cannabis supplier in Australia, to launch CraftPlant, a medical cannabis brand. Aurora Cannabis Inc. produces a range of products, including dried flowers, oils, and soft gels.
For Detailed Report: https://www.datamintelligence.com/enquiry/cbd-oil-market
